Chongqing 12 batches of drugs are not qualified 7 pharmaceutical companies deny that they have production

On November 13, the Chongqing Municipal Drug Administration issued a notice that 12 batches of drugs did not meet the regulations.
seven of them deny they have production.
order to strengthen drug quality supervision and management, standardize market order and ensure the safety of public drug use, our bureau organized relevant units to carry out drug sampling.
by the Chongqing Food and Drug Inspection and Testing Research Institute and other inspection institutions, marked as Hebei Chufeng Chinese medicine tablets Co., Ltd. and other 11 enterprises produced 12 batches of drugs do not meet the requirements.
, by the Chongqing Food and Drug Inspection and Inspection Research Institute, marked as Hebei Chufeng Chinese medicine tablets Co. , Ltd. production of plate blue root (lot number B710091-01) characteristics, content determination does not meet the requirements.
marked as Sichuan Shengsheng Jinrong Pharmaceutical Co., Ltd. Mai Dong (lot number 180901) is not compliant.
is marked as Shanxi Weihe Pharmaceutical Co. , Ltd. production of U-turned-aubergine aluminum capsule III (lot number 190201) content determination does not meet the requirements.
is marked as Liangshan Xinxin Chinese medicine tablets Co. , Ltd. production of wine ooze snake (lot number 190601) identification does not meet the requirements.
, by the Chongqing Yongchuan Food and Drug Inspection Institute, marked as Sichuan Zhongyong Pharmaceutical Co., Ltd. production of the first Uto (lot number T04517Q01) certificate does not meet the requirements.
3, by the Chongqing Lingling Food and Drug Inspection Institute, marked as Sichuan Kangquantang Chinese medicine tablets Co. , Ltd. production of bone fat (lot number 171101) content determination does not meet the requirements.
is marked as Changshu City Qingren Chinese medicine tablets Co. , Ltd. production of the former Hu (lot number 201901244) content determination does not meet the requirements.
labeled as gansu Province, Gansu National Herbal Medicine Co., Ltd. production of white appendages (lot number 18110101) leaching materials do not comply with the regulations.
, by the Chongqing Wanzhou Food and Drug Inspection Institute, marked as Anhui Jishun Chinese medicine tablets Co. , Ltd. production of red flowers (lot number 181001) nature, inspection does not meet the requirements.
marked as Yibinren and Chinese medicine drink tablets limited liability company production of the content determination of the decisive son (lot number 190501) and fried acid kernel (lot number 190501) characteristics, identification does not meet the requirements.
5, by the Chongqing Lujiang Food and Drug Inspection Institute, marked as Sichuan Gukang Pharmaceutical Co., Ltd. production of Sichuan shot dry (lot number 190301) nature does not meet the requirements.
the above non-compliant products, the Chongqing Municipal Drug Administration has tasked the relevant units to take the necessary control measures such as seizure, seizure, suspension of sales, recall, and other relevant laws and regulations to investigate and punish.
, November 6, 2020 Annex: 12 batches of non-compliant drugs list Note: the label "